Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
DICE Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Jun 2023.
DICE Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Jun 2023 was 5.9%, a 13% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)
DICE Therapeutics, Inc. Quarterly Debt-to-equity (%)
Period
Value
YoY Chg
Change %
Date
Q2 2023
5.9%
-0.87%
-13%
30 Jun 2023
Q1 2023
6.3%
31 Mar 2023
Q4 2022
7.5%
31 Dec 2022
Q3 2022
7.9%
30 Sep 2022
Q2 2022
6.7%
30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.